IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q3 2017 Holdings

Filed 2017-11-14 | 7 holdings | $131.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entellus MED IncCOM29363K105$54.6K2,956,45641.4%
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$32.6K1,716,30324.7%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$17.4K2,579,49013.2%
Transenterix IncCOM NEW89366M201$10.8K7,546,6928.2%
Ocular Therapeutix Inc(OCUL)COM67576A100$9.9K1,605,2077.5%
Catabasis Pharmaceuticals inCOM14875P107$6.1K2,857,6674.6%
Lombard MED IncCOMG55598109$5741,275,7790.4%